Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SORD | Q00796 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6585366 | 1.00 | SORD (1.00) | SORD | |
| SCHEMBL6586568 | 1.00 | SORD (1.00) | SORD | |
| SCHEMBL6587912 | 0.85 | SORD (1.00) | SORD | |
| SCHEMBL6585270 | 0.85 | SORD (1.00) | SORD | |
| SCHEMBL6590209 | 0.85 | SORD (0.73) | SORD | |
| SCHEMBL6585040 | 0.84 | SORD (0.76) | SORD | |
| Dimethylamine SCHEMBL7930897 | 0.82 | SORD (0.70) | SORD | |
| SCHEMBL7588700 | 0.80 | SORD (0.68) | SORD | |
| SCHEMBL6584718 | 0.80 | SORD (0.69) | SORD | |
| SCHEMBL29941725 | 0.79 | SORD (1.00) | SORD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041068-B1 | Compounds for treating and preventing diabetic complications | PFIZER PROD INC (US) | 2004-04-14 | — | — | EP | disclosed |
| US-6294538-B1 | ANTIDIABETIC AGENTS AND DIABETIC NEUROPATHY, TREATMENT WITH OXIDOREDUCTASE ENZYMES | PFIZER INC. | 2001-09-25 | — | — | US | disclosed |
| JP-2000297075-A | COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF DIABETIC COMPLICATION | PFIZER PROD INC | 2000-10-24 | — | — | JP | disclosed |
| EP-1041068-A1 | Compounds for treating and preventing diabetic complications | Pfizer Products Inc. (US) | 2000-10-04 | — | — | EP | disclosed |